Approvals/TGA/TEVATIAPINE XR quetiapine (as fumarate) 300 mg modified release tablet blister pack

Approved

STANDARD

TEVATIAPINE XR quetiapine (as fumarate) 300 mg modified release tablet blister pack

Teva Pharma Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 7f59ad7f981b3172
Product Name: TEVATIAPINE XR quetiapine (as fumarate) 300 mg modified release tablet blister pack
Artg Id: 249792
Artg Name: TEVATIAPINE XR quetiapine (as fumarate) 300 mg modified release tablet blister pack
Sponsor: Teva Pharma Australia Pty Ltd
Company Detail Path: /organization/teva-pharma-australia-pty-ltd
Artg Date: 2016-07-14
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2017-CMI-01660-1
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2016-PI-02228-1

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

7f59ad7f981b3172

Type

Standard